Navigation Links
Gov. Doyle comments on unlocking the power of power of stem cell research

The time has come to reexamine the federal policy on stem cell research.

MADISON - Wisconsin finds itself at the center of this debate, because our state is the birthplace of human embryonic stem cell research. In 1998, Dr. Jamie Thomson at the University of Wisconsin-Madison announced that ......

Full article >>> ntial of this research.

At the University of Wisconsin, Dr. Thomson has access to a highly advanced scientific laboratory. But the Bush policy has forced him to spend his time raising private money to build a separate, private lab at another location to derive new stem cell lines for research.

But privately funded research isn't the answer. For one thing, there isn't nearly......

Full article >>> ormer First Lady Nancy Reagan. She has spoken eloquently, and convincingly, that it is time to let science go forward. America should listen to her.

My mother suffers from Parkinson disease. Our family is no different from the Reagans or millions of others across this nation w......

Full article >>>
'"/>

Source:wistechnology.com By Gov. Jim Doyle 07/06/04


Related biology technology :

1. Doyle urges Legislature to support biofuels program
2. Doyle urges support of higher education spending
3. Doyle announces technology tax credits for Berbee
4. Doyle joins governors in support of stem cell bill
5. Doyle announces new energy, global warming policies
6. Doyle outlines spending for Medical College, UWM
7. Doyle wants sales tax applied to digital downloads
8. Doyle proposes $2M for venture capital center
9. Doyle seeks $30M for e-medical record adoption
10. Doyle says Congress should lift stem cell restrictions
11. Kanavas rips Doyle for taxing Internet
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... , Feb. 24, 2017 Provectus Biopharmaceuticals, ... the "Company"), a clinical-stage oncology and dermatology biopharmaceutical ... deadline to participate in its previously announced rights ... of shares of common stock and Series C ... of listed warrants. As previously ...
(Date:2/24/2017)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing and stem ... for the third quarter and first nine months of ... Third Quarter of Fiscal 2017 Highlights ... by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... host a Key Opinion Leader event to highlight new ... and poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology ... event will be held in-person and via live webcast ... 9:00 AM PST at the Lotte New York Palace ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
Breaking Biology Technology:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
(Date:2/8/2017)...  Aware, Inc. (NASDAQ: AWRE ), a leading ... for its quarter and year ended December 31, 2016. ... $3.9 million compared to $6.9 million in the same quarter ... was $0.6 million compared to $2.6 million in the fourth ... 2016 was $0.5 million, or $0.02 per diluted share, which ...
Breaking Biology News(10 mins):